ROYAL BANK OF CANADA - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,000
-43.5%
5,501
+53.9%
0.00%
Q2 2023$23,000
+91.7%
3,574
+73.0%
0.00%
Q1 2023$12,000
-70.0%
2,066
-47.3%
0.00%
Q4 2022$40,000
+471.4%
3,919
+846.6%
0.00%
Q3 2022$7,000
+133.3%
414
+117.9%
0.00%
Q2 2022$3,000
-88.5%
190
-88.4%
0.00%
Q1 2022$26,000
-79.4%
1,634
-72.3%
0.00%
Q4 2021$126,000
+447.8%
5,901
+271.1%
0.00%
Q3 2021$23,000
+27.8%
1,590
+72.5%
0.00%
Q2 2021$18,0009220.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders